{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T11:59:45Z","timestamp":1764935985049},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mitochondrial fission regulator 2 (MTFR2) was involved in the progression and development of various cancers. However, the relationship between MTFR2 with lung adenocarcinoma (LUAD) had not been reported. Herein, this study analyzed the clinical significance and potential mechanisms of MTFR2 in LUAD via bioinformatics tools.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that the level of MTFR2 was increased, and correlated with sex, age, smoking history, neoplasm staging, histological subtype and TP53 mutation status in LUAD patients. Kaplan-Meier survival analysis showed LUAD patients with increased MTFR2 had a poor prognosis. In addition, univariate COX regression analysis showed neoplasm staging, T stage, distant metastasis and MTFR2 level were risk factors for the prognosis of LUAD. A total of 1127 genes were coexpressed with MTFR2, including 840 positive and 208 negative related genes. KEGG and GSEA found that MTFR2 participated in the progression of LUAD by affecting cell cycle, DNA replication, homologous recombination, p53 signaling pathway and other mechanisms. The top 10 coexpressed genes, namely CDK1, CDC20, CCNB1, PLK1, CCNA2, AURKB, CCNB2, BUB1B, MAD2L1 and BUB1 were highly expressed, and were associated with poor prognosis in LUAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Consequently, we elucidated MTFR2 was a biomarker for diagnosis and poor prognosis in LUAD, and might participate in the progression of LUAD via affecting cell cycle, DNA replication, homologous recombination and p53 signaling pathway.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08378-3","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T23:08:57Z","timestamp":1622070537000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics"],"prefix":"10.1186","volume":"21","author":[{"given":"Cheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Dong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Bin","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Yong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Xiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Xian","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"issue":"5","key":"8378_CR1","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/1759-7714.13072","volume":"10","author":"Y Song","year":"2019","unstructured":"Song Y, Chen D, Zhang X, Luo Y, Li S. Integrating genetic mutations and expression profiles for survival prediction of lung adenocarcinoma. Thoracic Cancer. 2019;10(5):1220\u20138. https:\/\/doi.org\/10.1111\/1759-7714.13072.","journal-title":"Thoracic Cancer"},{"issue":"2","key":"8378_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/cas.14231","volume":"111","author":"QY Chen","year":"2020","unstructured":"Chen QY, Zhong Q, Zhou JF, Qiu XT, Dang XY, Cai LS, et al. Conditional survival and recurrence of remnant gastric cancer after surgical resection: a multi-institutional study. Cancer Sci. 2020;111(2):502\u201312. https:\/\/doi.org\/10.1111\/cas.14231.","journal-title":"Cancer Sci"},{"issue":"9","key":"8378_CR3","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.7150\/ijms.36071","volume":"16","author":"K Mizutani","year":"2019","unstructured":"Mizutani K, Guo X, Shioya A, Zhang J, Zheng J, Kurose N, et al. The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma. Int J Med Sci. 2019;16(9):1199\u2013206. https:\/\/doi.org\/10.7150\/ijms.36071.","journal-title":"Int J Med Sci"},{"issue":"7","key":"8378_CR4","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00262-017-1986-y","volume":"66","author":"R Okita","year":"2017","unstructured":"Okita R, Maeda A, Shimizu K, Nojima Y, Saisho S, Nakata M. PD-L1 overexpression is partially regulated by EGFR\/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer. Cancer Immunol Immunother. 2017;66(7):865\u201376. https:\/\/doi.org\/10.1007\/s00262-017-1986-y.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"8378_CR5","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/j.cllc.2018.01.002","volume":"19","author":"M Khunger","year":"2018","unstructured":"Khunger M, Jain P, Rakshit S, Pasupuleti V, Hernandez AV, Stevenson J, et al. Safety and efficacy of PD-1\/PD-L1 inhibitors in treatment-naive and chemotherapy-refractory patients with non-small-cell lung Cancer: a systematic review and meta-analysis. Clin Lung Cancer. 2018;19(3):e335\u201348. https:\/\/doi.org\/10.1016\/j.cllc.2018.01.002.","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"8378_CR6","doi-asserted-by":"publisher","first-page":"12329","DOI":"10.1038\/s41598-019-48243-9","volume":"9","author":"YH Jan","year":"2019","unstructured":"Jan YH, Lai TC, Yang CJ, Huang MS, Hsiao M. A co-expressed gene status of adenylate kinase 1\/4 reveals prognostic gene signature associated with prognosis and sensitivity to EGFR targeted therapy in lung adenocarcinoma. Sci Rep. 2019;9(1):12329. https:\/\/doi.org\/10.1038\/s41598-019-48243-9.","journal-title":"Sci Rep"},{"key":"8378_CR7","doi-asserted-by":"publisher","first-page":"116941","DOI":"10.1016\/j.lfs.2019.116941","volume":"237","author":"J Feng","year":"2019","unstructured":"Feng J, Ma Y, Chen Z, Hu J, Yang Q, Ding G. Mitochondrial pyruvate carrier 2 mediates mitochondrial dysfunction and apoptosis in high glucose-treated podocytes. Life Sci. 2019;237:116941. https:\/\/doi.org\/10.1016\/j.lfs.2019.116941.","journal-title":"Life Sci"},{"issue":"22","key":"8378_CR8","doi-asserted-by":"publisher","first-page":"10203","DOI":"10.18632\/aging.102442","volume":"11","author":"G Lu","year":"2019","unstructured":"Lu G, Lai Y, Wang T, Lin W, Lu J, Ma Y, et al. Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells. Aging. 2019;11(22):10203\u201319. https:\/\/doi.org\/10.18632\/aging.102442.","journal-title":"Aging"},{"key":"8378_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mito.2019.07.003","volume":"49","author":"Y Wu","year":"2019","unstructured":"Wu Y, Chen M, Jiang J. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion. 2019;49:35\u201345. https:\/\/doi.org\/10.1016\/j.mito.2019.07.003.","journal-title":"Mitochondrion"},{"key":"8378_CR10","doi-asserted-by":"crossref","unstructured":"Zhou Q, Li H, Li Y, Tan M, Fan S, Cao C, et al. Inhibiting neddylation modification alters mitochondrial morphology and reprograms energy metabolism in cancer cells. JCI Insight. 2019;4(4):e121582.","DOI":"10.1172\/jci.insight.121582"},{"key":"8378_CR11","doi-asserted-by":"publisher","first-page":"110029","DOI":"10.1016\/j.biopha.2020.110029","volume":"125","author":"Y Zeng","year":"2020","unstructured":"Zeng Y, Guo Z, Hu Z, Liu M, Chen Y, Chen S, et al. FGD1 exhibits oncogenic properties in hepatocellular carcinoma through regulating cell morphology, autophagy and mitochondrial function. Biomed Pharmacother. 2020;125:110029.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"8378_CR12","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.18632\/oncotarget.23152","volume":"9","author":"J Wang","year":"2018","unstructured":"Wang J, Xie Y, Bai X, Wang N, Yu H, Deng Z, et al. Targeting dual specificity protein kinase TTK attenuates tumorigenesis of glioblastoma. Oncotarget. 2018;9(3):3081\u20138. https:\/\/doi.org\/10.18632\/oncotarget.23152.","journal-title":"Oncotarget"},{"key":"8378_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.chemosphere.2016.11.065","volume":"169","author":"M Yang","year":"2017","unstructured":"Yang M, Wang B, Gao J, Zhang Y, Xu W, Tao L. Spinosad induces programmed cell death involves mitochondrial dysfunction and cytochrome C release in Spodoptera frugiperda Sf9 cells. Chemosphere. 2017;169:155\u201361. https:\/\/doi.org\/10.1016\/j.chemosphere.2016.11.065.","journal-title":"Chemosphere"},{"issue":"1\u20132","key":"8378_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11010-020-03701-1","volume":"467","author":"S Yang","year":"2020","unstructured":"Yang S, Liu Y, Guo Y, Liu R, Qi F, Li X, et al. Circadian gene clock participates in mitochondrial apoptosis pathways by regulating mitochondrial membrane potential, mitochondria out membrane permeablization and apoptosis factors in AML12 hepatocytes. Mol Cell Biochem. 2020;467(1\u20132):65\u201375. https:\/\/doi.org\/10.1007\/s11010-020-03701-1.","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"8378_CR15","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1002\/cam4.916","volume":"5","author":"B Pan","year":"2016","unstructured":"Pan B, Zhong W, Deng Z, Lai C, Chu J, Jiao G, et al. Inhibition of prostate cancer growth by solanine requires the suppression of cell cycle proteins and the activation of ROS\/P38 signaling pathway. Cancer Medicine. 2016;5(11):3214\u201322. https:\/\/doi.org\/10.1002\/cam4.916.","journal-title":"Cancer Medicine"},{"issue":"2","key":"8378_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/15384101.2017.1407892","volume":"17","author":"M Yue","year":"2018","unstructured":"Yue M, Li S, Yan G, Li C, Kang Z. Paeoniflorin inhibits cell growth and induces cell cycle arrest through inhibition of FoxM1 in colorectal cancer cells. Cell cycle (Georgetown, Tex). 2018;17(2):240\u20139.","journal-title":"Cell cycle (Georgetown, Tex)"},{"issue":"4","key":"8378_CR17","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/cas.13524","volume":"109","author":"W Li","year":"2018","unstructured":"Li W, Zheng G, Xia J, Yang G, Sun J, Wang X, et al. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer. Cancer Sci. 2018;109(4):1012\u201323. https:\/\/doi.org\/10.1111\/cas.13524.","journal-title":"Cancer Sci"},{"issue":"21","key":"8378_CR18","doi-asserted-by":"publisher","first-page":"6196","DOI":"10.1158\/0008-5472.CAN-18-1377","volume":"78","author":"BA Nichols","year":"2018","unstructured":"Nichols BA, Oswald NW, McMillan EA, McGlynn K, Yan J, Kim MS, et al. HORMAD1 is a negative prognostic Indicator in lung adenocarcinoma and specifies resistance to oxidative and genotoxic stress. Cancer Res. 2018;78(21):6196\u2013208. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-1377.","journal-title":"Cancer Res"},{"key":"8378_CR19","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.2147\/OTT.S190934","volume":"12","author":"H Sun","year":"2019","unstructured":"Sun H, Liu K, Huang J, Sun Q, Shao C, Luo J, et al. FAM111B, a direct target of p53, promotes the malignant process of lung adenocarcinoma. OncoTargets Ther. 2019;12:2829\u201342. https:\/\/doi.org\/10.2147\/OTT.S190934.","journal-title":"OncoTargets Ther"},{"issue":"8","key":"8378_CR20","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.4161\/cc.10.8.15353","volume":"10","author":"M Nihal","year":"2011","unstructured":"Nihal M, Stutz N, Schmit T, Ahmad N, Wood GS. Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs), and its downregulation promotes cell cycle arrest and apoptosis. Cell Cycle (Georgetown, Tex). 2011;10(8):1303\u201311.","journal-title":"Cell Cycle (Georgetown, Tex)"},{"issue":"4","key":"8378_CR21","doi-asserted-by":"publisher","first-page":"e507","DOI":"10.1016\/j.ijrobp.2012.05.035","volume":"84","author":"P Raghavan","year":"2012","unstructured":"Raghavan P, Tumati V, Yu L, Chan N, Tomimatsu N, Burma S, et al. AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cells. Int J Radiat Oncol Biol Phys. 2012;84(4):e507\u201314. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.05.035.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"8378_CR22","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1245\/s10434-012-2727-2","volume":"20","author":"E Ko","year":"2013","unstructured":"Ko E, Kim Y, Cho EY, Han J, Shim YM, Park J, et al. Synergistic effect of Bcl-2 and cyclin A2 on adverse recurrence-free survival in stage I non-small cell lung cancer. Ann Surg Oncol. 2013;20(3):1005\u201312. https:\/\/doi.org\/10.1245\/s10434-012-2727-2.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"8378_CR23","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.7150\/jca.41415","volume":"11","author":"F Kou","year":"2020","unstructured":"Kou F, Sun H, Wu L, Li B, Zhang B, Wang X, et al. TOP2A promotes lung adenocarcinoma Cells' malignant progression and predicts poor prognosis in lung adenocarcinoma. J Cancer. 2020;11(9):2496\u2013508. https:\/\/doi.org\/10.7150\/jca.41415.","journal-title":"J Cancer"},{"issue":"2","key":"8378_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1593\/neo.07112","volume":"9","author":"DR Rhodes","year":"2007","unstructured":"Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007;9(2):166\u201380. https:\/\/doi.org\/10.1593\/neo.07112.","journal-title":"Neoplasia"},{"issue":"21","key":"8378_CR25","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108\u201310. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307.","journal-title":"Cancer Res"},{"issue":"8","key":"8378_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649\u201358. https:\/\/doi.org\/10.1016\/j.neo.2017.05.002.","journal-title":"Neoplasia"},{"key":"8378_CR27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fgene.2020.00242","volume":"11","author":"Q Guo","year":"2020","unstructured":"Guo Q, Ke XX, Liu Z, Gao WL, Fang SX, Chen C, et al. Evaluation of the prognostic value of STEAP1 in lung adenocarcinoma and insights into its potential molecular pathways via Bioinformatic analysis. Front Genet. 2020;11:242. https:\/\/doi.org\/10.3389\/fgene.2020.00242.","journal-title":"Front Genet"},{"issue":"12","key":"8378_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082241","volume":"8","author":"B Gy\u0151rffy","year":"2013","unstructured":"Gy\u0151rffy B, Surowiak P, Budczies J, L\u00e1nczky A. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One. 2013;8(12):e82241. https:\/\/doi.org\/10.1371\/journal.pone.0082241.","journal-title":"PLoS One"},{"key":"8378_CR29","doi-asserted-by":"publisher","first-page":"632837","DOI":"10.3389\/fmolb.2021.632837","volume":"8","author":"X Li","year":"2021","unstructured":"Li X, Sun L, Wang X, Wang N, Xu K, Jiang X, et al. A five immune-related lncRNA signature as a prognostic target for glioblastoma. Front Mol Biosci. 2021;8:632837. https:\/\/doi.org\/10.3389\/fmolb.2021.632837.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"8378_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"8378_CR31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ygyno.2018.03.057","volume":"149","author":"H Wu","year":"2018","unstructured":"Wu H, Zhang J. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: a study based on TCGA data. Gynecol Oncol. 2018;149(3):592\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2018.03.057.","journal-title":"Gynecol Oncol"},{"issue":"D1","key":"8378_CR32","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49(D1):D605\u201312. https:\/\/doi.org\/10.1093\/nar\/gkaa1074.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"8378_CR33","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/s41598-020-79235-9","volume":"11","author":"H Ma","year":"2021","unstructured":"Ma H, He Z, Chen J, Zhang X, Song P. Identifying of biomarkers associated with gastric cancer based on 11 topological analysis methods of CytoHubba. Sci Rep. 2021;11(1):1331. https:\/\/doi.org\/10.1038\/s41598-020-79235-9.","journal-title":"Sci Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08378-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08378-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08378-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T23:21:51Z","timestamp":1622071311000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08378-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8378"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08378-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"assertion":[{"value":"20 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"619"}}